Cimzia

certolizumab pegol

On June 4, 2008, the Food and Drug Administration (FDA) said it is investigating a potential link between four rheumatoid arthritis drugs and the increased risk of cancer in children. The investigation was prompted after the agency received 30 reports of cancer in 10 years among children and young adults treated with the drugs. Cimzia is included in the investigation.